Rock Springs Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Rock Springs Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-250,000	Closed	-$3.11M	–	142
2016 Q4	$3.11M	Buy	250,000 +225,000	+900%	+$2.71M	0.21%	98
2016 Q3	$342K	Buy	+25,000	New	+$251K	0.02%	137

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Rock Springs Capital Management's ARIA Position: Q1 2017 in Review

Rock Springs Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 250,000 shares — an estimated $3.11M sold.

Rock Springs Capital Management first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $3.11M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Rock Springs Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Rock Springs Capital Management sold 250,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.11M.
Rock Springs Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
Rock Springs Capital Management's Ariad Pharmaceuticals Inc position peaked at $3.11M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Rock Springs Capital Management's 13F filing for Q1 2017, filed 15 May 2017.